Literature DB >> 20725867

Unraveling the role of metal ions and low catalytic activity of cytochrome C oxidase in Alzheimer's disease.

Trevor Alleyne1, Neetu Mohan, Jerome Joseph, Andrew Adogwa.   

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by high levels of aluminum and certain other metal ions in the brain: The disease is also characterized by low activity of brain cytochrome c oxidase (COX) but whether the elevated metal ions and the low COX activity are linked is not known. Moreover, COX is known to exhibit two catalytic rates (V (max)) and two substrate binding constants (K (m)) but it is not known which of these is affected in AD. In this study, we employed the Klatzo AD rabbit model to evaluate the impact of elevated metal ions on brain COX activity. New Zealand white rabbits were injected intra-cerebrally with 1.4% solutions of either AlCl(3), FeCl(3), CaCl(2), or MgCl(2); and 10 days, later the brain mitochondria were isolated. Polarographic assay revealed that compared to the controls, all four metals led to decreases in the V (max) of the enzyme's low affinity site. The respective decreases were; 16%, 36%, 18%, and 30%. The results suggest a sequence of events in vivo in which oxygen radical damage to mitochondria and COX leads to low ATP production and excess heme establishing conditions thought to be ideal for neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20725867     DOI: 10.1007/s12031-010-9436-8

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  38 in total

1.  Proton involvement in the transition from the "peroxy" to the ferryl intermediate of cytochrome c oxidase.

Authors:  M Fabian; G Palmer
Journal:  Biochemistry       Date:  2001-02-13       Impact factor: 3.162

2.  Acceleration of phosphatidylcholine synthesis and breakdown by inhibitors of mitochondrial function in neuronal cells: a model of the membrane defect of Alzheimer's disease.

Authors:  S A Farber; B E Slack; J K Blusztajn
Journal:  FASEB J       Date:  2000-11       Impact factor: 5.191

3.  Correlation of the kinetics of electron transfer activity of various eukaryotic cytochromes c with binding to mitochondrial cytochrome c oxidase.

Authors:  S Ferguson-Miller; D L Brautigan; E Margoliash
Journal:  J Biol Chem       Date:  1976-02-25       Impact factor: 5.157

4.  Amyloid-beta peptide binds with heme to form a peroxidase: relationship to the cytopathologies of Alzheimer's disease.

Authors:  Hani Atamna; Kathleen Boyle
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

5.  Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure.

Authors:  V N Uversky; J Li; A L Fink
Journal:  J Biol Chem       Date:  2001-09-11       Impact factor: 5.157

6.  Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease.

Authors:  T W Kim; W H Pettingell; Y K Jung; D M Kovacs; R E Tanzi
Journal:  Science       Date:  1997-07-18       Impact factor: 47.728

7.  Single catalytic site model for the oxidation of ferrocytochrome c by mitochondrial cytochrome c oxidase.

Authors:  S H Speck; D Dye; E Margoliash
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

Review 8.  Biological markers of Alzheimer's disease and mild cognitive impairment.

Authors:  Ricardo B Maccioni; Manuel Lavados; Cristobal B Maccioni; Ariadna Mendoza-Naranjo
Journal:  Curr Alzheimer Res       Date:  2004-11       Impact factor: 3.498

9.  Coordination of ATP production and consumption in brain: parallel regulation of cytochrome oxidase and Na+, K(+)-ATPase.

Authors:  R F Hevner; R S Duff; M T Wong-Riley
Journal:  Neurosci Lett       Date:  1992-04-13       Impact factor: 3.046

10.  Enzymatic characterization of cathepsin D in rabbit brains with experimental neurofibrillary changes.

Authors:  H Suzuki; M Takeda; T Nishimura
Journal:  Biochem Mol Biol Int       Date:  1994-04
View more
  5 in total

Review 1.  Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.

Authors:  J Eva Selfridge; Lezi E; Jianghua Lu; Russell H Swerdlow
Journal:  Neurobiol Dis       Date:  2012-01-10       Impact factor: 5.996

Review 2.  Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.

Authors:  Calvin C Willhite; Nataliya A Karyakina; Robert A Yokel; Nagarajkumar Yenugadhati; Thomas M Wisniewski; Ian M F Arnold; Franco Momoli; Daniel Krewski
Journal:  Crit Rev Toxicol       Date:  2014-10       Impact factor: 5.635

3.  Brain Transcriptome Sequencing of a Natural Model of Alzheimer's Disease.

Authors:  Francisco Altimiras; Barbara Uszczynska-Ratajczak; Francisco Camara; Anna Vlasova; Emilio Palumbo; Stephen Newhouse; Robert M J Deacon; Leandro A E Farias; Michael J Hurley; David E Loyola; Rodrigo A Vásquez; Richard Dobson; Roderic Guigó; Patricia Cogram
Journal:  Front Aging Neurosci       Date:  2017-03-20       Impact factor: 5.750

Review 4.  Mechanisms of Neuronal Protection against Excitotoxicity, Endoplasmic Reticulum Stress, and Mitochondrial Dysfunction in Stroke and Neurodegenerative Diseases.

Authors:  Howard Prentice; Jigar Pravinchandra Modi; Jang-Yen Wu
Journal:  Oxid Med Cell Longev       Date:  2015-10-20       Impact factor: 6.543

Review 5.  Effects and Mechanisms of Taurine as a Therapeutic Agent.

Authors:  Stephen Schaffer; Ha Won Kim
Journal:  Biomol Ther (Seoul)       Date:  2018-05-01       Impact factor: 4.634

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.